Co-morbid and socio-demographic factors associated with cognitive performance in an elderly community dwelling Irish population

International Journal of Geriatric Psychiatry

Volumn 21, Issue 12, 2006, Pages 1150-1155

  Chin, Ai Vyrn ^a   O'Connell, Henry ^a   Kirby, Michael ^a   Denihan, Aisling ^a   Bruce, Irene ^a   Walsh, J B ^a   Coakley, David ^a   Lawlor, Brian A ^a   Cunningham, Conal ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

Cognition; Elderly; Epidemiology; Risk factors

Indexed keywords

BENZODIAZEPINE DERIVATIVE; HYPNOTIC AGENT; LITHIUM SALT; NEUROLEPTIC AGENT; NORADRENALIN UPTAKE INHIBITOR; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AGE; AGED; ANXIETY; ARTICLE; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; DEMOGRAPHY; DEPRESSION; EDUCATION; EPILEPSY; FEMALE; HUMAN; HYPERTENSION; INTERVIEW; IRELAND; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; MULTIVARIATE ANALYSIS; PARKINSON DISEASE; RISK FACTOR; SMOKING; SOCIOECONOMICS; STATISTICAL SIGNIFICANCE; STROKE;

AGE FACTORS; AGED; AGED, 80 AND OVER; CEREBROVASCULAR ACCIDENT; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DEMENTIA; EDUCATIONAL STATUS; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTROPIC DRUGS; RISK FACTORS; SOCIAL CLASS;

EID: 33845937336     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1621     Document Type: Article

References (49)

1. Aguero-Torres H, Thomas VS, Winblad B, Fratiglioni L. 2002. The impact of somatic and cognitive disorders on the functional status of the elderly. J Clin Epidemiol 55: 1007-1012.
2. Allard J, Artero S, Ritchie K. 2003. Consumption of psychotropic medication in the elderly: a re-evaluation of its effect on cognitive performance. Int J Geriatr Psychiatry 18: 874-878.
3. Almeida OP, Hulse GK, Lawrence D, Flicker L. 2002. Smoking as a risk factor for Alzheimer's disease: contrasting evidence from a systematic review of case-control and cohort studies. Addiction 97: 15-28.
4. Alvarado BE, Zunzunegui MV, Del Ser T, Beland F. 2002. Cognitive decline is related to education and occupation in a Spanish elderly cohort. Aging Clin Exp Res 14: 132-142.
5. Ancelin ML, Artero S, Portet F, Dupuy AM, et al. 2006. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 332: 455-459.
6. Ballard C, Margallo-Lana M, Juszczak E, et al. 2005. Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial. BMJ 330: 874.
7. Barbone F, McMahon AD, Davey PG, et al. 1998. Association of road-traffic accidents with benzodiazepine use. Lancet 352: 1331-1336.
8. Biringer E, Mykletun A, Dahl A.A. 2005. The association between depression, anxiety, and cognitive function in the elderly general population-the Hordaland Health Study. Int J Geriatr Psychiatry 20: 989-997.
9. British National Formulary. 2006. BMJ Publishing Group and Royal Pharmaceutical Society of Great Britain. ISBN:0 85369 668 3.
10. Burt DB, Zembar MJ, Niederehe G. 1995. Depression and memory impairment: a meta-analysis of the association, its pattern, and specificity. Psychol Bull 117: 285-305.
11. Central Statistics Office Ireland. http://www.cso.ie. Last accessed 10th Oct 2005.
12. Clark MS, Dennerstein L, Elkadi S, et al. 2004. Normative verbal and non-verbal memory test scores for Australian women aged 56-67. Aust N Z J Psychiatry 38: 532-540.
13. Copeland JR, Dewey ME, Griffiths-Jones HM. 1986. A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol Med 16: 89-99.
14. Coulson I, Strang V, Marino R, Minichiello V. 2004. Knowledge and lifestyle behaviors of healthy older adults related to modifying the onset of vascular dementia. Arch Gerontol Geriatr 39: 43-58.
15. Dealberto MJ, McAvay GJ, Seeman T, Berkman L. 1997. Psychotropic drug use and cognitive decline among older men and women. Int J Geriatr Psychiatry 12: 567-574.
16. Denihan A, Kirby M, Bruce I, et al. 2000. Three-year prognosis of depression in the community-dwelling elderly. Br J Psychiatry 176: 453-457.
17. Doll R, Peto R, Boreham J, Sutherland I. 2000. Smoking and dementia in male British doctors: prospective study. BMJ 320: 1097-1102.
18. Evans DA, Hebert LE, Beckett LA, et al. 1997. Education and other measures of socioeconomic status and risk incident Alzheimer disease in a defined population of older persons. Arch Neurol 54: 1399-1405.
19. Folstein MF, Folstein SE, McHugh PR. 1975. 'Mini-Mental State'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
20. Fuhrer R, Antonucci TC, Gagnon M, et al. 1992. Depressive symptomatology and cognitive functioning: an epidemiological survey in an elderly community sample in France. Psychol Med 22: 159-172.
21. Geerlings MI, Schoevers RA, Beekman AT, et al. 2000. Depression and risk of cognitive decline and Alzheimer's disease. Results of two prospective community-based studies in The Netherlands. Br J Psychiatry 176: 568-575.
22. Glynn RJ, Beckett LA, Hebert LE, et al. 1999. Current and remote blood pressure and cognitive decline. JAMA 281: 438-445.
23. Greiner PA, Snowdon DA, Schmitt FA. 1996. The loss of independence in activities of daily living: the role of low normal cognitive function in elderly nuns. Am J Public Health 86: 62-66.
24. Group SCR. 1991. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265: 3255-3264.
25. Hogan DB, Maxwell CJ, Fung TS, Ebly EM. 2003. Prevalence and potential consequences of benzodiazepine use in senior citizens: results from the Canadian Study of Health and Aging. Can J Clin Pharmacol 10: 72-77.
26. Ivan CS, Seshadri S, Beiser A, Au R, et al. 2004. Dementia after stroke: the Framingham Study. Stroke 35: 1264-1268.
27. Kirby M, Bruce I, Radic A, et al. 1997. Mental disorders among the community-dwelling elderly in Dublin. Br J Psychiatry 171: 369-372.
28. Kirby M, Denihan A, Bruce I, et al. 1999. Benzodiazepine use among the elderly in the community. Int J Geriatr Psychiatry 14: 280-284.
29. Kivipelto M, Helkala EL, Laakso MP, et al. 2001. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 322: 1447-1451.
30. Kizilbash AH, Vanderploeg RD, Curtiss G. 2002. The effects of depression and anxiety on memory performance. Arch Clin Neuropsychol 17: 57-67.
31. Lee PN. 1994. Smoking and Alzheimer's disease: a review of the epidemiological evidence. Neuroepidemiology 13: 131-144.
32. Lindsay J, Laurin D, Verreault R, et al. 2002. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 156: 445-453.
33. Lyness SA, Eaton EM, Schneider LS. 1994. Cognitive performance in older and middle-aged depressed outpatients and controls. J Gerontol 49: P129-136.
34. McShane R, Keene J, Gedling K, et al. 1997. Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up. BMJ 314: 266-270.
35. Ott A, Andersen K, Dewey ME, et al. 2004. Effect of smoking on global cognitive function in nondemented elderly. Neurology 62: 920-924.
36. Paterniti S, Dufouil C, Bisserbe JC, Alperovitch A. 1999. Anxiety, depression, psychotropic drug use and cognitive impairment. Psychol Med 29: 421-428.
37. Paterniti S, Dufouil C, Alperovitch A. 2002. Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study. J Clin Psychopharmacol 22: 285-293.
38. Posner HB, Tang MX, Luchsinger J, et al. 2002. The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology 58: 1175-1181.
39. Snowdon DA, Greiner LH, Mortimer JA, et al. 1997. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277: 813-817.
40. Srikanth VK, Thrift AG, Saling MM, et al. 2003. Increased risk of cognitive impairment 3 months after mild to moderate first-ever stroke: a Community-Based Prospective Study of Nonaphasic English-Speaking Survivors. Stroke 34: 1136-1143.
41. Stenbacka M, Jansson B, Leifman A, Romelsjo A. 2002. Association between use of sedatives or hypnotics, alcohol consumption, or other risk factors and a single injurious fall or multiple injurious falls: a longitudinal general population study. Alcohol 28: 9-16.
42. Tatemichi TK, Paik M, Bagiella E, et al. 1994. Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology 44: 1885-1891.
43. Tombaugh TN, McIntyre NJ. 1992. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 40: 922-935.
44. Tuokko H, Frerichs R, Graham J, et al. 2003. Five-year follow-up of cognitive impairment with no dementia. Arch Neurol 60: 577-582.
45. Unverzagt FW, Gao S, Baiyewu O, et al. 2001. Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging. Neurology 57: 1655-1662.
46. van Ojen I, Hooijer C, Bezemer D, Jonker C. et al. 1995a. Late-life depressive disorder in the community. I. The relationship between MMSE score and depression in subjects with and without psychiatric history. Br J Psychiatry 166: 311-315; 319.
47. Verghese J, Lipton RB, Hall CB, et al. 2003. Low blood pressure and the risk of dementia in very old individuals. Neurology 61: 1667-1672.
48. Vignola A, Lamoureux C, Bastien CH, Morin CM. 2000. Effects of chronic insomnia and use of benzodiazepines on daytime performance in older adults. J Gerontol B Psychol Sci Soc Sci 55: P54-62.
49. Wagner AK, Zhang F, Soumerai SB, et al. 2004. Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med 164: 1567-1572.